• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严格治疗的克罗恩病患者同时补充钙和维生素 D 可增加骨密度。

Increase in bone mineral density in strictly treated Crohn's disease patients with concomitant calcium and vitamin D supplementation.

机构信息

Department of Gastroenterology and Hepatology, VU University Medical Centre, PO Box 7057, The Netherlands.

出版信息

J Crohns Colitis. 2013 Jun;7(5):377-84. doi: 10.1016/j.crohns.2012.06.003. Epub 2012 Jun 27.

DOI:10.1016/j.crohns.2012.06.003
PMID:22749232
Abstract

BACKGROUND AND AIMS

Decreased bone mineral density (BMD) is common in Crohn's disease (CD) patients. This paper reports on the prevalence of decreased BMD in a referral cohort study of CD-patients next to the change of BMD over time in relation with CD-associated clinical characteristics.

METHODS

205 CD patients of a referral hospital were enrolled between January1998-January 2010 when measurement of BMD by dual X-ray absorptiometry (DXA) was available. Follow-up DXA scan was performed in subjects with known risk factors besides Crohn indicative for low BMD. Treatment of CD patients was according to a protocol which is comparable to the current (inter)national guidelines. In osteopenic patients, supplemental vitamin D (800 IU) and Calcium (500-1000 mg) were prescribed.

RESULTS

Mean BMD at baseline was 0.97 ± 0.16 gram/cm(2) in lumbar spine and 0.87 ± 0.12 gram/cm(2) in the total hip. At baseline, higher age and low Body Mass Index (BMI), were negatively correlated with BMD. Eighty-four patients underwent a second BMD assessment with a median interval period of 4 years (IQR 3-6). A mean annual increase of +0.76% (95%CI: -2.63%; +3.87%) in lumbar spine and +0.43% (95%CI: -2.65% ; +1.11%) in total hip was observed.

CONCLUSIONS

Higher age, male sex, low BMI, and a higher age at diagnosis of CD were associated with low BMD. Follow-up of BMD in CD patients showed a contraintuitive small increase of BMD at lumbar spine and total hip in CD patients only using supplemental vitamin D and calcium next to strict treatment of CD.

摘要

背景和目的

骨质疏松症在克罗恩病(CD)患者中很常见。本文报告了在一家转诊医院的 CD 患者队列研究中,与 CD 相关的临床特征相比,BMD 随时间变化的同时,BMD 降低的患病率。

方法

1998 年 1 月至 2010 年 1 月,当可进行双能 X 线吸收法(DXA)测量 BMD 时,纳入了 205 例转诊医院的 CD 患者。在已知有低 BMD 风险因素且提示为 CD 的患者中,进行了后续 DXA 扫描。CD 患者的治疗根据与当前(国际)国家指南相媲美的方案进行。在骨质疏松症患者中,开具了维生素 D(800 IU)和钙(500-1000 mg)补充剂。

结果

基线时腰椎的平均 BMD 为 0.97 ± 0.16 克/厘米(2),总髋部的平均 BMD 为 0.87 ± 0.12 克/厘米(2)。基线时,年龄较大和较低的体重指数(BMI)与 BMD 呈负相关。84 例患者进行了第二次 BMD 评估,中位间隔时间为 4 年(IQR 3-6)。腰椎的平均年增长率为+0.76%(95%CI:-2.63%;+3.87%),总髋部的平均年增长率为+0.43%(95%CI:-2.65%;+1.11%)。

结论

较高的年龄、男性、较低的 BMI 和 CD 的诊断年龄较高与低 BMD 相关。仅使用补充维生素 D 和钙以及严格治疗 CD 的情况下,CD 患者的 BMD 随访显示腰椎和总髋部的 BMD 呈反直觉的小幅度增加。

相似文献

1
Increase in bone mineral density in strictly treated Crohn's disease patients with concomitant calcium and vitamin D supplementation.严格治疗的克罗恩病患者同时补充钙和维生素 D 可增加骨密度。
J Crohns Colitis. 2013 Jun;7(5):377-84. doi: 10.1016/j.crohns.2012.06.003. Epub 2012 Jun 27.
2
Treatment of bone loss in osteopenic patients with Crohn's disease: a double-blind, randomised trial of oral risedronate 35 mg once weekly or placebo, concomitant with calcium and vitamin D supplementation.骨质疏松症合并克罗恩病患者的骨丢失治疗:口服利塞膦酸钠 35mg 每周一次或安慰剂,同时补充钙和维生素 D 的双盲、随机试验。
Gut. 2014 Sep;63(9):1424-30. doi: 10.1136/gutjnl-2013-305523. Epub 2013 Oct 21.
3
Risedronate improves bone mineral density in Crohn's disease: a two year randomized controlled clinical trial.利塞膦酸钠可改善克罗恩病患者的骨密度:一项为期两年的随机对照临床试验。
J Crohns Colitis. 2012 Aug;6(7):777-86. doi: 10.1016/j.crohns.2012.01.004. Epub 2012 Feb 10.
4
Bone mineral density in patients with inflammatory bowel disease: a population-based prospective two-year follow-up study.炎症性肠病患者的骨矿物质密度:一项基于人群的前瞻性两年随访研究。
Scand J Gastroenterol. 2004 Feb;39(2):145-53. doi: 10.1080/00365520310007873.
5
Decreased bone density in inflammatory bowel disease is related to corticosteroid use and not disease diagnosis.炎症性肠病中骨密度降低与使用皮质类固醇有关,而非与疾病诊断有关。
J Bone Miner Res. 1995 Feb;10(2):250-6. doi: 10.1002/jbmr.5650100211.
6
Randomized trial of etidronate plus calcium and vitamin D for treatment of low bone mineral density in Crohn's disease.依替膦酸二钠联合钙和维生素D治疗克罗恩病低骨矿物质密度的随机试验
Clin Gastroenterol Hepatol. 2005 Feb;3(2):122-32. doi: 10.1016/s1542-3565(04)00663-9.
7
A single dose of intravenous zoledronate prevents glucocorticoid therapy-associated bone loss in acute flare of Crohn's disease, a randomized controlled trial.一项随机对照试验表明,单次静脉注射唑来膦酸可预防克罗恩病急性发作时糖皮质激素治疗相关的骨丢失。
Am J Gastroenterol. 2011 Apr;106(4):786-93. doi: 10.1038/ajg.2011.59. Epub 2011 Mar 8.
8
Clinical Course of Bone Metabolism Disorders in Patients with Inflammatory Bowel Disease: A 5-Year Prospective Study.炎症性肠病患者骨代谢紊乱的临床病程:一项5年的前瞻性研究。
Inflamm Bowel Dis. 2016 Aug;22(8):1929-36. doi: 10.1097/MIB.0000000000000815.
9
Osteopenia and osteoporosis in Crohn's disease: prevalence in a Dutch population-based cohort.克罗恩病中的骨质减少和骨质疏松症:荷兰人群队列中的患病率
Scand J Gastroenterol Suppl. 2000(232):43-7.
10
Bone mineral density in Iranian patients with inflammatory bowel disease.伊朗炎症性肠病患者的骨矿物质密度
Int J Colorectal Dis. 2006 Dec;21(8):758-66. doi: 10.1007/s00384-005-0084-3. Epub 2006 Feb 4.

引用本文的文献

1
Health Maintenance and Unique Health Needs of the Perimenopausal and Postmenopausal Woman with Inflammatory Bowel Disease.患有炎症性肠病的围绝经期和绝经后女性的健康维护及特殊健康需求。
Dig Dis Sci. 2025 Jul 8. doi: 10.1007/s10620-025-09199-1.
2
Gut, bone, and muscle: the triad of osteosarcopenia in inflammatory bowel disease.肠道、骨骼与肌肉:炎症性肠病中的骨肌减少三联征
Intest Res. 2025 Jul;23(3):254-289. doi: 10.5217/ir.2024.00185. Epub 2025 Apr 29.
3
A practical approach to positioning therapies in ulcerative colitis.溃疡性结肠炎定位治疗的实用方法。
J Can Assoc Gastroenterol. 2025 Feb 21;8(Suppl 2):S6-S14. doi: 10.1093/jcag/gwae058. eCollection 2025 Mar.
4
Pathogenesis of Musculoskeletal Deficits in Children and Adults with Inflammatory Bowel Disease.炎症性肠病患儿和成人的肌肉骨骼缺陷发病机制。
Nutrients. 2021 Aug 23;13(8):2899. doi: 10.3390/nu13082899.
5
Perspective on skeletal health in inflammatory bowel disease.炎症性肠病中的骨骼健康观。
Osteoporos Int. 2020 Apr;31(4):637-646. doi: 10.1007/s00198-019-05234-w. Epub 2019 Dec 10.
6
British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults.英国胃肠病学会成人炎症性肠病管理共识指南。
Gut. 2019 Dec;68(Suppl 3):s1-s106. doi: 10.1136/gutjnl-2019-318484. Epub 2019 Sep 27.
7
Micronutrient Absorption and Related Outcomes in People with Inflammatory Bowel Disease: A Review.炎症性肠病患者的微量营养素吸收及相关结局:综述。
Nutrients. 2019 Jun 20;11(6):1388. doi: 10.3390/nu11061388.
8
The Role of Vitamin D in Inflammatory Bowel Disease: Mechanism to Management.维生素 D 在炎症性肠病中的作用:从发病机制到治疗策略。
Nutrients. 2019 May 7;11(5):1019. doi: 10.3390/nu11051019.
9
Assessment of Sex Differences for Treatment, Procedures, Complications, and Associated Conditions Among Adolescents Hospitalized with Crohn's Disease.克罗恩病住院青少年患者治疗、手术、并发症及相关病症的性别差异评估
Inflamm Bowel Dis. 2015 Nov;21(11):2619-24. doi: 10.1097/MIB.0000000000000521.
10
Candidate genes involved in beneficial or adverse responses to commonly eaten brassica vegetables in a New Zealand Crohn's disease cohort.与新西兰克罗恩病队列中常吃的十字花科蔬菜的有益或不利反应相关的候选基因。
Nutrients. 2013 Dec 12;5(12):5046-64. doi: 10.3390/nu5125046.